These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23248118)

  • 1. Application of a proapoptotic peptide to intratumorally spreading cancer therapy.
    Chen R; Braun GB; Luo X; Sugahara KN; Teesalu T; Ruoslahti E
    Cancer Res; 2013 Feb; 73(4):1352-61. PubMed ID: 23248118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells.
    Yao X; Jennings S; Ireland SK; Pham T; Temple B; Davis M; Chen R; Davenport I; Biliran H
    PLoS One; 2014; 9(7):e101564. PubMed ID: 25003198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.
    Brunquell C; Biliran H; Jennings S; Ireland SK; Chen R; Ruoslahti E
    Mol Cancer Res; 2012 Nov; 10(11):1482-95. PubMed ID: 22952044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
    Huang Y; Li X; Sha H; Zhang L; Bian X; Han X; Liu B
    Oncol Rep; 2017 Apr; 37(4):2063-2070. PubMed ID: 28260064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase D is a positive regulator of Bit1 apoptotic function.
    Biliran H; Jan Y; Chen R; Pasquale EB; Ruoslahti E
    J Biol Chem; 2008 Oct; 283(42):28029-37. PubMed ID: 18703509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
    Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
    Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancer.
    Yang J; Yang J; Wei Y; Yin H; Fang L; Chai D; Li H; Li H; Zhang Q; Zheng J
    Int Immunopharmacol; 2019 May; 70():125-134. PubMed ID: 30798161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment.
    Huang Y; Li X; Sha H; Zhang L; Bian X; Han X; Liu B
    Sci Rep; 2017 Apr; 7(1):579. PubMed ID: 28373646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.
    Yao X; Gray S; Pham T; Delgardo M; Nguyen A; Do S; Ireland SK; Chen R; Abdel-Mageed AB; Biliran H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1240-1248. PubMed ID: 29170133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anoikis effector Bit1 negatively regulates Erk activity.
    Kairouz-Wahbe R; Biliran H; Luo X; Khor I; Wankell M; Besch-Williford C; Pascual J; Oshima R; Ruoslahti E
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1528-32. PubMed ID: 18218778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bit1 in anoikis resistance and tumor metastasis.
    Jenning S; Pham T; Ireland SK; Ruoslahti E; Biliran H
    Cancer Lett; 2013 Jun; 333(2):147-51. PubMed ID: 23376255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis of tumor cells is enhanced by downregulation of Bit1.
    Karmali PP; Brunquell C; Tram H; Ireland SK; Ruoslahti E; Biliran H
    PLoS One; 2011; 6(8):e23840. PubMed ID: 21886829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against human bit1, an apoptosis-associated mitochondrial protein.
    Hua W; Chen B; Zhang W; Miao S; Zhang H; Xin X
    Hybridoma (Larchmt); 2009 Jun; 28(3):167-71. PubMed ID: 19519243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice.
    Hu C; Chen X; Huang Y; Chen Y
    Chem Biol Drug Des; 2018 Aug; 92(2):1567-1575. PubMed ID: 29722179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
    PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological implication and function of Bcl2-inhibitor of transcription in ovarian serous papillary adenocarcinomas.
    Hua W; Miao S; Zou W; Yang H; Chen BL
    Neoplasma; 2013; 60(2):143-50. PubMed ID: 23259782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.
    Sha H; Zou Z; Xin K; Bian X; Cai X; Lu W; Chen J; Chen G; Huang L; Blair AM; Cao P; Liu B
    J Control Release; 2015 Feb; 200():188-200. PubMed ID: 25553823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting.
    Lingasamy P; Laarmann AH; Teesalu T
    Curr Cancer Drug Targets; 2021; 21(1):70-79. PubMed ID: 33001014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways.
    Bouchentouf M; Benabdallah BF; Rousseau J; Schwartz LM; Tremblay JP
    Am J Transplant; 2007 Jun; 7(6):1491-505. PubMed ID: 17511679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.